Sorrento Therapeutics Inc (SRNE)

[dia76ca]

FIRST there's a $34 million grant from DARPA to develop COVI-PLASMID DNA.

NOW a multi-year deal with another branch of DOD for four more programs. "Initial focus of the collaboration is to improve infectious disease readiness through surveillance and clinical diagnostic validation activities for COVISTIX/COVITRACK Diagnostic Tests and COVIDROPS/COVI-AMG neutralizing antibody treatments for COVID-19 patients."

This is a clear sign that the DOD has done due diligence and like what they see. This is only the beginning of a growing relationship.